15May 2026
India’s First Alzheimer’s Therapy Approved
INDIA’S FIRST ALZHEIMER’S DISEASE-MODIFYING THERAPY Why in the News? Drug Launch: Eli Lilly launched donanemab in India under the brand name Lormalzi for Alzheimer’s treatment. First Therapy: It is the first Alzheimer’s disease-modifying therapy commercially launched in India for early-stage patients. High Cost: The treatment costs around ₹91,688 per dose and requires monthly infusions for …
Read More
